Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials

[1] Sieper J(2017)Axial spondyloarthritis Lancet. 390 73-84

[2] Poddubnyy D(2014)The concept of spondyloarthritis: where are we now? Best Pract Res Clin Rheumatol 28 663-672

[3] Garg N(2016)Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis Arthritis Res Ther 18 196-959

[4] van den Bosch F(2008)Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review Ann Rheum Dis 67 955-943

[5] Deodhar A(2016)Adalimumab in patients with active noninfectious uveitis N Engl J Med 375 932-1192

[6] de Winter JJ(2016)Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial Lancet. 388 1183-1634

[7] van Mens LJ(2006)Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study Ann Rheum Dis 65 1631-2451

[8] van der Heijde D(2005)Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept Arthritis Rheum 52 2447-1521

[9] Landewé R(2017)Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register Ann Rheum Dis 76 1515-1848

[10] Baeten DL(2014)Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis J Rheumatol 41 1843-844

[1] Sieper J(2017)Axial spondyloarthritis Lancet. 390 73-84

[2] Poddubnyy D(2014)The concept of spondyloarthritis: where are we now? Best Pract Res Clin Rheumatol 28 663-672

[3] Garg N(2016)Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis Arthritis Res Ther 18 196-959

[4] van den Bosch F(2008)Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review Ann Rheum Dis 67 955-943

[5] Deodhar A(2016)Adalimumab in patients with active noninfectious uveitis N Engl J Med 375 932-1192

[6] de Winter JJ(2016)Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial Lancet. 388 1183-1634

[7] van Mens LJ(2006)Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study Ann Rheum Dis 65 1631-2451

[8] van der Heijde D(2005)Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept Arthritis Rheum 52 2447-1521

[9] Landewé R(2017)Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register Ann Rheum Dis 76 1515-1848

[10] Baeten DL(2014)Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis J Rheumatol 41 1843-844